Sleep apnoea screening
Scientifically validated and also medically certified, Sleepacta has developed Dormi Apnea, a specific algorithm for estimating the risk of sleep apnoea, of particular interest to various medical areas such as the dental sleep medicine, neurological and pulmonological clinical areas.
Pharmaceutical Industry
As of today, with Dormi, companies producing drugs or supplements can make use of a customized output to identify sleep disorders in order to suggest the use of specific supplements or to monitor the actual effectiveness of a given therapy or treatment afterwards.
Research Centres
Through a simple download of the raw data, the Dormi database is available to research centers with different clinical objectives: often to share the large amount of data acquired during years of research and clinical trials.
Both public and private hospital facilities
The future of diagnostics lies in the adoption of increasingly smarter and less invasive tools, technologies and modalities that are nevertheless capable of providing reliable and certified answers at reduced costs. Meeting all these requirements, Dormi is already an alternative system to polysomnography for many hospitals and as a screening tool for the detection of sleep-related disorders, turning out to be interesting to different specialist areas (psychiatry, neurology, pneumology).
Sports medicine
It is now well established that the quality of sports performance is closely linked to the quality of sleep. This is why Sleepacta has launched a project, in collaboration with AKERN, to develop a dedicated solution for Sport Medicine experts.
Paediatrics
Sleep disorders in children, affecting patients and their parents, are a very common phenomenon. Dormi represents, especially for children, a non-invasive diagnostic system that gains higher compliance (even over a longer period of time) due to the ease of application than polysomnography. For this reason, it has been adopted as a screening system for a pilot study project for an oral supplement line of products financed by the company Steve Jones - “Buona”, with the participation of Stella Maris and the approval of the Meyer Ethics Committee with Prof. Ugo Faraguna and Dr. Simona Fiori, a child neuropsychiatrist and researcher at UNIPI, as scientific Project Leads.
Occupational medicine and insurance
The effects of sleep deprivation on deteriorating work performance in adults are well known. Dormi is one of the tools that can detect, in a simple and effective way, conditions of lack of well-being or psychophysical balance due to non-restful, of particular interest in shift workers or employees with special duties.
